Orforglipron is an oral, non-peptide glucagon-like peptide-1 receptor agonist under clinical investigation for type 2 diabetes. It is a complex polycyclic compound with multiple aromatic rings and heterocycles, used as an active pharmaceutical ingredient in research.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Orforglipron?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Orforglipron hemicalcium hydrate
pharmaceutical raw material
AOD 9604
pharmaceutical raw material
Olanzapine pamoate hydrate
pharmaceutical raw material
25-hydroxy-7-dehydrocholesterol
pharmaceutical raw material
Dexketoprofen
pharmaceutical raw material
The international HS code for Orforglipron (CAS 2212020-52-3) is 2934.99.
2934.99
2934 99 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
3-[(1S,2S)-1-[5-[(4S)-2,2-dimethyloxan-4-yl]-2-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl]-4-methyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-5-carbonyl]indol-1-yl]-2-methylcyclopropyl]-4H-1,2,4-oxadiazol-5-one
USUWIEBBBWHKNI-KHIFEHGGSA-N
C[C@H]1C[C@]1(C2=NOC(=O)N2)N3C4=C(C=C(C=C4)[C@H]5CCOC(C5)(C)C)C=C3C(=O)N6CCC7=NN(C(=C7[C@@H]6C)N8C=CN(C8=O)C9=C(C1=C(C=C9)N(N=C1)C)F)C1=CC(=C(C(=C1)C)F)C
Sourcing Orforglipron?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.